UnitedHealth Group Incorporated (UNH)
UnitedHealth Shows Signs of Turnaround With Strong Quarterly Results
The healthcare giant detailed corporate changes and upgraded its full-year outlook
UnitedHealthcare Reducing Need For Prior Approvals For Patients In Rural America
UnitedHealthcare, the nation's largest health insurance company, Monday said it will exempt rural physicians and hospitals from “prior authorization requirements across all lines of business.”
Buy UnitedHealth Ahead Of Earnings (Preview)
UnitedHealth Group is positioned as a turnaround play, with management prioritizing margin expansion over top-line growth for 2026-2027. Recent CMS rate increases and Optum Health restructuring support a bullish outlook, with incremental revenue and operating profit potential not fully priced in. UNH trades near the bottom of its historical P/E range, offering 30%+ upside if margins recover and forward multiples normalize.
How Much Is UnitedHealth Group Stock Expected to Move After Earnings?
UnitedHealth Group (UNH) is scheduled to release before the opening bell on Tuesday, with traders pricing in the possibility the stock could return to positive territory for the year following the report.
UnitedHealth Group: Poised To Challenge The $360 Resistance
UnitedHealth Group Incorporated is poised for a substantial margin recovery, with FQ1 2026 EPS projected at $6.62 and net margin rebounding to 5.53%. Further margin expansion is likely too, thanks to its strategic repricing, AI-driven efficiency gains, and a 2.48% Medicare Advantage rate increase. UNH trades at a forward P/E of 17.7, about 13% below its five-year average, suggesting sizable undervaluation.
UnitedHealth: Buy Before Earnings Confirm Margin Recovery
UnitedHealth is positioned for a sharp re-rating after a 48% drawdown driven by Medicare Advantage margin compression, cost trends, and operational disruptions. The final 2027 CMS Medicare Advantage rate notice at 2.48%—far above initial expectations—unlocks ~$1B incremental 2027 operating profit and enables renewed competitive positioning. Management's aggressive repricing, benefit cuts, and cost actions have set up a 2026 margin recovery, with guidance for $24B+ operating earnings and a 30bps MCR improvement.
Heard on the Street: Investors betting on UnitedHealth to return soon to fat margins and premium valuations are likely to be disappointed
The government delayed an overhaul to how it calculates Medicare Advantage payments. For the insurer, that only postpones the pain.
UnitedHealth Q1 Earnings Preview: Can it Dodge MA Pressure for a Beat?
UNH heads into Q1 2026 earnings with costs rising and membership slipping, but growing services revenue and steady insurance operating income could keep a beat alive.
Gear Up for UnitedHealth (UNH) Q1 Earnings: Wall Street Estimates for Key Metrics
Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
UnitedHealth vs. Elevance: Which Healthcare Stock Has More Upside?
UNH's integrated Optum engine and earnings stability give it an edge over ELV as shifting costs and policy changes reshape managed care dynamics.
Falling Stock Price, Rising Dividend: UnitedHealth Fits the Dogs of the Dow Profile
The Dogs of the Dow is one of the oldest contrarian income strategies in investing.
Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound
Next week's UnitedHealth Group quarterly earnings are greatly anticipated for signs the health insurance giant and its rivals are getting a handle on rising costs dragging down the managed care industry.
